Literature DB >> 8943569

CD45 up-regulation during lymphocyte maturation.

J Kirberg1, T Brocker.   

Abstract

CD4+ CD8+ double-positive thymocytes differentiate into CD4+ and CD8+ single-positive T cells during thymic positive selection. This process requires the interaction between the TCR and self MHC molecules. In this context we have analyzed the expression of CD45, an abundant transmembrane protein tyrosine phosphatase, and describe here its differential surface expression during T cell maturation. Using four-color FACS analysis of thymocytes from normal as well as TCR-transgenic mice we demonstrate that CD45 is up-regulated only during positive selection concomitantly with the TCR-CD3 complex and the transient early activation marker CD69, but that this up-regulation precedes heat stable antigen down-regulation. The tight linkage of the up-regulation of the TCR-CD3 complex and CD45 may be required because the CD45 tyrosine phosphatase plays a role in modulating signal transduction by the TCR-CD3 complex during positive selection. In addition, our findings argue for a regulation mechanism that adapts the CD45 levels to increasing antigen receptor levels on mature T cells and B cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943569     DOI: 10.1093/intimm/8.11.1743

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  3 in total

1.  Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules.

Authors:  J Kirberg; A Berns; H von Boehmer
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

2.  Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells.

Authors:  T Brocker
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

Review 3.  Maturation and emigration of single-positive thymocytes.

Authors:  Xi Xu; Shusong Zhang; Pingping Li; Jin Lu; Qun Xuan; Qing Ge
Journal:  Clin Dev Immunol       Date:  2013-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.